Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate-Reference-Cited by-同舟云学术

Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate

Published:2020-09-23 Issue:12 Volume:43 Page:865-871
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Janzen Bryan W.,Ong Aldrich,Penner Makoy,Koul Rashmi,Dubey Arbind,Ahmed Shahida,Bashir Bashir,Chowdhury Amitava,Dawe David E.,Nayak Jasmir,Kim Julian O.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference41 articles.

1. Management algorithms for prostate-specific antigen progression in prostate cancer: biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer;Danielson;Can Urol Assoc J,2019

2. Intermittent androgen deprivation in prostate cancer cases with biochemical progression after radical prostatectomy: are we ready to treat?;Cattarino;Crit Rev Oncol Hematol,2016

3. Studies on prostatic cancer i. the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

4. Androgen deprivation therapy for prostate cancer;Sharifi;JAMA,2005

5. Intermittent androgen suppression for rising PSA level after radiotherapy;Crook;N Engl J Med,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of androgen deprivation therapy on bone mineral density in patients with prostate cancer;Pakistan Journal of Medical Sciences;2022-04-26

2. Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain;F1000Research;2022-04-21

3. Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain;F1000Research;2021-10-21